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Background and purpose
We sought to evaluate the influence of infarct size on inf-
arct healing and left ventricular (LV) remodeling in
patients with a first, successfully reperfused ST-elevation
myocardial infarction (STEMI) using MRI.
Methods and results
Fifty-eight patients were studied in the first week (1 W)
and 4 months (4 M) after the acute event. At 1 W, infarct
size was related to infarct transmurality (r = 0.62, p <
0.001), infarct surface (r = 0.78, p < 0.001), circumferen-
tial and longitudinal infarct length (r = 0.67, p < 0.001
and r = 0.69, p < 0.001, respectively), concomitant micro-
vascular obstruction (r = 0.74, p < 0.001), area at risk (r =
0.78, p < 0.001) as well as the ratio of infarct size to area
at risk (r = 0.68, p < 0.001), and inversely related to systo-
lic wall thickening in the infarct (r = 0.45, p < 0.001) and
peri-infarct area (r = 0.37, p = 0.004), and LV EF (r = 0.59,
p < 0.001). The median of normalized infarct size at 1 W,
ie, 17.1% of LV mass, was used to create a small and large
size infarct group. Large infarcts presented with higher
maximum serum troponin I levels than small infarcts
(115 ± 68 μg/L versus 60 ± 28 μg/L, p = 0.003. While
shrinkage in infarct size at 4 M was similar between
groups (43 ± 18% in small versus 42 ± 16% in large inf-
arcts, p = 0.99), the infarct surface did shrink significantly
more in small (15.7 ± 15.9%) than large infarcts (4.0 ±
11.9%), p = 0.005 with most pronounced differences in
longitudinal direction, i.e. 14.5 ± 12.5% in small versus
5.0 ± 8.6% in large infarcts, p = 0.003. On the other hand,
thinning of the infarcted wall was more pronounced in
large (29.8 ± 18.8%) than in small infarcts (13.5 ± 22%),
p = 0.004. Functionally, small infarcts recovered systolic
wall thickening in the infarct (p = 0.01) and peri-infarct
area (p = 0.004), matching with improvement in LV EF
(52.7 ± 7.0% at 1 W tot 55.7 ± 7.3% at 4 M, p = 0.003),
while large infarcts showed a lack of recovery in regional
or global LV function. At 1 W, large infarcts showed more
pronounced flattening of the infarcted myocardium as
expressed by a larger circumferential radius of curvature (p
= 0.019). At 4 M infarct size was related to expansion of
the remote myocardium (circumferential radius of curva-
ture at end diastole: r = 0.45, p = 0.001, end systole: r =
0.54, p = 0.001), and global adverse remodeling (LV EDV
r = 0.39, p = 0.003; LV ESV r = 0.58, p < 0.001, LV EF r = -
0.61, p < 0.001).
Conclusion
The amount of necrotic myocardium strongly determines
the pattern of infarct healing, and regional and global LV
remodeling. Small infarcts show favorable infarct healing
(less thinning, more surface shrinkage) and remodeling
with a beneficial impact on regional and global function.
Large infarcts, in contrast, show more extensive infarct
thinning, lack of infarct surface shrinkage leading to
adverse remodeling, and lack of functional recovery.
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